Are Anti-Receptor-Binding Domain Antibodies Still a Relevant Proxy for Monitoring SARS-CoV-2 Neutralizing Activity in the Omicron Era?

被引：5
|
作者：
Saker, Kahina [1 ]
Pozzetto, Bruno [2 ,3 ]
Bal, Antonin [1 ]
Valette, Martine [1 ]
Fassier, Jean-Baptiste [4 ]
Saade, Carla [1 ,2 ]
Trabaud, Mary Anne [1 ]
Trouillet-Assant, Sophie [1 ,2 ]
机构：
[1] Hosp Civils Lyon, Virol Lab, Inst Infect Agents, Lab Associated,Natl Ref Ctr Resp Viruses, F-69317 Lyon 04, France
[2] Claude Bernard Lyon 1 Univ, Univ St Etienne, CIRI, Int Ctr Res Infect,INSERM U111 CNRS UMR 5308, F-69008 Lyon, France
[3] Univ Hosp St Etienne, Dept Infect Agents & Hyg, F-42270 St Priest En Jarez, France
[4] Hosp Civils Lyon, Occupat Hlth & Med Dept, F-69317 Lyon 04, France
来源：
CLINICAL CHEMISTRY | 2022年 / 68卷 / 07期
关键词：
D O I：
10.1093/clinchem/hvac085
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：984 / 986
页数：3
相关论文
共 50 条
  • [31] A therapeutic neutralizing antibody targeting receptor binding domain of SARS-CoV-2 spike protein
    Cheolmin Kim
    Dong-Kyun Ryu
    Jihun Lee
    Young-Il Kim
    Ji-Min Seo
    Yeon-Gil Kim
    Jae-Hee Jeong
    Minsoo Kim
    Jong-In Kim
    Pankyeom Kim
    Jin Soo Bae
    Eun Yeong Shim
    Min Seob Lee
    Man Su Kim
    Hanmi Noh
    Geun-Soo Park
    Jae Sang Park
    Dain Son
    Yongjin An
    Jeong No Lee
    Ki-Sung Kwon
    Joo-Yeon Lee
    Hansaem Lee
    Jeong-Sun Yang
    Kyung-Chang Kim
    Sung Soon Kim
    Hye-Min Woo
    Jun-Won Kim
    Man-Seong Park
    Kwang-Min Yu
    Se-Mi Kim
    Eun-Ha Kim
    Su-Jin Park
    Seong Tae Jeong
    Chi Ho Yu
    Youngjo Song
    Se Hun Gu
    Hanseul Oh
    Bon-Sang Koo
    Jung Joo Hong
    Choong-Min Ryu
    Wan Beom Park
    Myoung-don Oh
    Young Ki Choi
    Soo-Young Lee
    Nature Communications, 12
  • [32] Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
    Srivastava, Vikram
    Niu, Ling
    Phadke, Kruttika S.
    Bellaire, Bryan H.
    Cho, Michael W.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [33] Enhanced elicitation of potent neutralizing antibodies by the SARS-CoV-2 spike receptor binding domain Fc fusion protein in mice
    Liu, Xianglei
    Drelich, Aleksandra
    Li, Wei
    Chen, Chuan
    Sun, Zehua
    Shi, Megan
    Adams, Cynthia
    Mellors, John W.
    Tseng, Chien-Te
    Dimitrov, Dimiter S.
    VACCINE, 2020, 38 (46) : 7205 - 7212
  • [34] Glycan engineering of the SARS-CoV-2 receptor-binding domain elicits cross-neutralizing antibodies for SARS-related viruses
    Shinnakasu, Ryo
    Sakakibara, Shuhei
    Yamamoto, Hiromi
    Wang, Po-Hung
    Moriyama, Saya
    Sax, Nicolas
    Ono, Chikako
    Yamanaka, Atsushi
    Adachi, Yu
    Onodera, Taishi
    Sato, Takashi
    Shinkai, Masaharu
    Suzuki, Ryosuke
    Matsuura, Yoshiharu
    Hashii, Noritaka
    Takahashi, Yoshimasa
    Inoue, Takeshi
    Yamashita, Kazuo
    Kurosaki, Tomohiro
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (12):
  • [35] Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant
    Parua, Pijus
    Ghosh, Somnath
    Jana, Koushik
    Seth, Arnab
    Debnath, Biplab
    Rout, Saroj Kumar
    Sarangi, Manoj Kumar
    Dash, Rasmita
    Halder, Jitu
    Rajwar, Tushar Kanti
    Pradhan, Deepak
    Rai, Vineet Kumar
    Dash, Priyanka
    Das, Chandan
    Kar, Biswakanth
    Ghosh, Goutam
    Rath, Goutam
    CURRENT PHARMACEUTICAL DESIGN, 2025, 31 (10) : 753 - 773
  • [36] Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
    Xiaojing Chi
    Xiuying Liu
    Conghui Wang
    Xinhui Zhang
    Xiang Li
    Jianhua Hou
    Lili Ren
    Qi Jin
    Jianwei Wang
    Wei Yang
    Nature Communications, 11
  • [37] Interaction of Receptor-Binding Domain of the SARS-CoV-2 Omicron Variant with hACE2 and Actin
    Fujimoto, Ai
    Kawai, Haruki
    Kawamura, Rintaro
    Kitamura, Akira
    CELLS, 2024, 13 (16)
  • [38] Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain
    Chi, Xiaojing
    Liu, Xiuying
    Wang, Conghui
    Zhang, Xinhui
    Li, Xiang
    Hou, Jianhua
    Ren, Lili
    Jin, Qi
    Wang, Jianwei
    Yang, Wei
    NATURE COMMUNICATIONS, 2020, 11 (01)
  • [39] Anti-Spike IgG antibodies as correlates of protection against SARS-CoV-2 infection in the pre-Omicron and Omicron era
    Seekircher, Lisa
    Astl, Manfred
    Tschiderer, Lena
    Wachter, Gregor A.
    Penz, Julia
    Pfeifer, Bernhard
    Huber, Andreas
    Afonso, Pedro M.
    Gaber, Manfred
    Schennach, Harald
    Siller, Anita
    Willeit, Peter
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (08)
  • [40] Structural basis for SARS-CoV-2 neutralizing antibodies with novel binding epitopes
    Fu, Dan
    Zhang, Guangshun
    Wang, Yuhui
    Zhang, Zheng
    Hu, Hengrui
    Shen, Shu
    Wu, Jun
    Li, Bo
    Li, Xin
    Fang, Yaohui
    Liu, Jia
    Wang, Qiao
    Zhou, Yunjiao
    Wang, Wei
    Li, Yufeng
    Lu, Zhonghua
    Wang, Xiaoxiao
    Nie, Cui
    Tian, Yujie
    Chen, Da
    Wang, Yuan
    Zhou, Xingdong
    Wang, Qisheng
    Yu, Feng
    Zhang, Chen
    Deng, Changjing
    Zhou, Liang
    Guan, Guangkuo
    Shao, Na
    Lou, Zhiyong
    Deng, Fei
    Zhang, Hongkai
    Chen, Xinwen
    Wang, Manli
    Liu, Louis
    Rao, Zihe
    Guo, Yu
    PLOS BIOLOGY, 2021, 19 (05)
12345